3-FMA Powder

€ 20,00

3-FMA Powder is a research material associated with 3-fluoromethamphetamine, a synthetic substituted amphetamine derivative distinguished by a fluorine substituent at the meta position of its aromatic ring. Raw Lab Chems identifies this material exclusively for controlled chemical identification, analytical characterization, structural comparison, and reference-oriented laboratory investigation. The supplied information describes high purity, independent testing, and batch documentation, but these claims require supporting records before they can be considered verified.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-S-12789 Category:
Description

3-FMA Powder – 3-Fluoromethamphetamine Research Material

Product Overview

3-FMA Powder is described in the supplied information as a laboratory research material associated with 3-fluoromethamphetamine, a synthetic fluorinated derivative of methamphetamine.

The compound belongs to the broader class of substituted amphetamines and phenethylamine derivatives.

Its chemical classification is relevant to analytical investigations involving molecular identification, structural comparison, and differentiation among fluorinated positional isomers.

Raw Lab Chems presents the material exclusively within a Research Use Only framework.

The supplied source describes a fine crystalline powder intended for controlled laboratory examination.

However, the stated physical presentation does not independently establish the actual chemical identity, purity, crystalline structure, or composition of the material.

The source also characterizes the preparation as laboratory-grade and refers to third-party verification and controlled manufacturing conditions.

These descriptions remain supplier-provided claims until supported by records associated with the actual batch.

No clinical, therapeutic, diagnostic, dietary, or consumer-oriented application is represented by this description.

Chemical Identity & Classification

3-FMA is the abbreviated name for 3-fluoromethamphetamine.

It is also described as a meta-fluorinated methamphetamine analog because the fluorine substituent occupies the 3-position of the aromatic ring.

The supplied source provides the following chemical-reference information:

  • Chemical name: 1-(3-Fluorophenyl)-N-methylpropan-2-amine
  • Common name: 3-Fluoromethamphetamine
  • Abbreviation: 3-FMA
  • CAS Registry Number: 1182818-14-5
  • Molecular formula: C10H14FN
  • Approximate molecular weight: 167.22 g/mol
  • Classification: Fluorinated substituted amphetamine derivative

These identifiers are reproduced from the supplied information and do not independently verify the composition of the actual product.

The source does not confirm whether the supplied preparation is the freebase or a particular salt form.

This distinction matters because chemical form can affect the appropriate molecular formula, molecular weight, and analytical reference information.

The compound’s meta-fluorinated structure distinguishes it from related fluorinated positional isomers.

Researchers seeking public chemical-reference information may consult PubChem, ensuring that the selected record corresponds to the correct chemical identity and form.

Chemical & Physical Characteristics

The supplied product is described as a fine crystalline powder.

No product-specific physical inspection record, microscopy report, diffraction dataset, or other evidence was provided to establish its actual appearance or crystalline state.

The stated physical form therefore remains a source-provided description.

The compound’s substituted aromatic structure provides a basis for chemical classification and comparison with related fluorinated amphetamine derivatives.

However, structural similarity does not establish identical physical properties, analytical behavior, stability, or impurity profiles.

No verified melting point, quantitative solubility profile, particle-size distribution, crystalline polymorph, density, or hygroscopicity measurement was supplied.

These characteristics should not be inferred from the common compound name.

The source recommends cool, dry storage protected from light.

It also specifies a recommended temperature of 2–8°C for longer-term storage.

No validated stability study, degradation profile, or experimentally established shelf-life specification accompanied this recommendation.

Purity & Analytical Verification

The supplied description claims purity of at least 98%, characterized as typical and independently verified.

However, no actual batch-specific Certificate of Analysis, chromatogram, mass spectrum, NMR spectrum, or independent laboratory report was provided.

Accordingly, the stated purity threshold is not independently confirmed for the material described here.

The source identifies HPLC, GC-MS, LC-MS, and NMR spectroscopy as analytical techniques associated with the investigation of substituted amphetamine derivatives.

Such methods may provide information concerning chemical identity, structural characteristics, impurity profiles, and analytical specificity.

However, naming an analytical technique does not establish that it was performed on the actual product.

For fluorinated positional isomers, analytical specificity is particularly important because related compounds can share molecular formulas and other structural features.

Researchers should distinguish general chemical-reference information from batch-specific experimental findings.

Any reported purity or identity result should be evaluated against the actual sample, method documentation, reference materials, and relevant analytical limitations.

Quality Control & Batch Integrity

The supplied source claims that individual batches undergo third-party testing and are supported by Certificates of Analysis.

It also describes batch tracking, independent verification of identity and purity, and manufacturing under ISO-compliant conditions.

No actual certificate, laboratory accreditation record, manufacturing audit, quality-system documentation, or batch-specific testing report accompanied these statements.

They therefore remain unverified supplier claims.

For reproducible laboratory investigation, useful documentation may include supplier identification, batch number, chemical identifier, receipt date, storage history, and available analytical findings.

Where a material is described as suitable for reference-standard work, researchers should distinguish ordinary catalog material from a certified reference material.

The supplied information does not establish certified reference-material status, metrological traceability, or an assigned measurement uncertainty.

Likewise, the description does not independently demonstrate compliance with a particular ISO standard.

Claims of consistent purity or identity should be supported by actual analytical records rather than inferred from catalog terminology.

Safety, Handling & Laboratory Precautions

3-Fluoromethamphetamine is an amphetamine-derived substance requiring appropriate institutional risk assessment and controlled laboratory handling.

Research personnel should consult applicable chemical-safety documentation and institutional procedures before receiving or examining the material.

Laboratory precautions should address access restrictions, protective equipment, contamination prevention, accidental exposure, environmental release, and chemical-waste disposal.

The source identifies the compound as a substituted amphetamine derivative.

This classification does not establish safety for human or veterinary exposure.

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

Because the actual purity and chemical form have not been independently confirmed, laboratory documentation should distinguish verified characteristics from supplier-provided statements.

The powder presentation must not be interpreted as evidence of pharmaceutical suitability or authorization for personal use.

Packaging, Labeling & Storage

The supplied source describes secure packaging, appropriate chemical labeling, and professional handling during transportation.

No packaging-validation study, verified container specification, or actual shipment-condition record accompanied these claims.

The source recommends storage in a cool, dry environment protected from light.

It additionally identifies 2–8°C as a recommended temperature range.

No validated stability data was provided to establish that this temperature range is necessary or sufficient for a particular shelf life.

Laboratory inventory records should preserve the compound name, any available batch identifier, receipt details, and relevant storage observations.

Where chemical form remains uncertain, the inventory record should preserve that uncertainty rather than assign an unverified salt designation.

Packaging and environmental requirements should be assessed using available safety documentation, relevant stability evidence, and institutional laboratory procedures.

Intended Research Use & Market Positioning

The supplied scientific context places 3-FMA within analytical research involving substituted amphetamine derivatives, fluorinated phenethylamines, chemical characterization, and positional-isomer comparison.

Its meta-fluorinated structure provides a basis for examining distinctions among related compounds within this chemical family.

The source also references chromatographic and spectroscopic analysis as areas of laboratory investigation.

These references describe analytical research contexts and do not establish any human-use application.

For comparative chemical-catalog research, Raw Lab Chems also lists 3-FMA Pellets and 3-FEA Powder.

The first listing identifies another presentation associated with 3-FMA, while the second concerns a distinct fluorinated ethamphetamine derivative.

These materials should not be assumed to have equivalent chemical forms, purity, formulation, or analytical characteristics.

The supplied 3-FMA Powder catalog reference identifies the product presentation discussed here.

These references provide chemical-catalog context rather than evidence of certified reference-material status or interchangeability.

Ordering, Availability & Fulfillment

The supplied source describes worldwide shipping, discreet packaging, tracking, and professional handling for research institutions.

No current inventory information, carrier record, destination-specific authorization, or verified shipment-performance documentation was provided.

Consequently, no specific availability, delivery, customs-clearance, or transportation guarantee is asserted.

Fluorinated methamphetamine derivatives may be subject to controlled-substance or analog legislation.

Institutional acquisition and transfer should therefore be assessed against the applicable laws governing the exact substance and chemical form involved.

Researchers and institutions should independently verify whether possession, importation, exportation, transportation, and laboratory investigation are authorized in their jurisdictions.

Research-only labeling does not establish an exemption from controlled-substance regulations.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

3-FMA is described as a fluorinated methamphetamine derivative whose legal classification may vary by jurisdiction.

Acquisition, possession, transfer, importation, exportation, storage, and laboratory investigation may be restricted or prohibited under applicable controlled-substance, analog, or other chemical regulations.

Researchers and institutions remain responsible for determining legal requirements and obtaining any necessary authorizations.

No medical approval, consumer-use authorization, universal legal status, or regulatory exemption is implied by this description.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “3-FMA Powder”
Shipping & Delivery